- Home
- IMCC vs BCTX Comparison
IMCC vs BCTX Comparison
Compare IMCC & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- BCTX
- Stock Information
- Founded
- IMCC 1980
- BCTX 2014
- Country
- IMCC Israel
- BCTX Canada
- Employees
- IMCC N/A
- BCTX N/A
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- BCTX Health Care
- Exchange
- IMCC Nasdaq
- BCTX Nasdaq
- Market Cap
- IMCC 11.8M
- BCTX 12.7M
- IPO Year
- IMCC N/A
- BCTX N/A
- Fundamental
- Price
- IMCC $2.56
- BCTX $0.78
- Analyst Decision
- IMCC
- BCTX Strong Buy
- Analyst Count
- IMCC 0
- BCTX 1
- Target Price
- IMCC N/A
- BCTX $32.00
- AVG Volume (30 Days)
- IMCC 50.5K
- BCTX 782.4K
- Earning Date
- IMCC 08-12-2025
- BCTX 06-16-2025
- Dividend Yield
- IMCC N/A
- BCTX N/A
- EPS Growth
- IMCC N/A
- BCTX N/A
- EPS
- IMCC N/A
- BCTX N/A
- Revenue
- IMCC $38,430,631.00
- BCTX N/A
- Revenue This Year
- IMCC $47.12
- BCTX N/A
- Revenue Next Year
- IMCC $12.83
- BCTX N/A
- P/E Ratio
- IMCC N/A
- BCTX N/A
- Revenue Growth
- IMCC 5.08
- BCTX N/A
- 52 Week Low
- IMCC $1.29
- BCTX $0.61
- 52 Week High
- IMCC $7.12
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- IMCC 45.77
- BCTX 27.72
- Support Level
- IMCC $2.52
- BCTX $0.61
- Resistance Level
- IMCC $3.13
- BCTX $0.75
- Average True Range (ATR)
- IMCC 0.33
- BCTX 0.05
- MACD
- IMCC -0.00
- BCTX 0.09
- Stochastic Oscillator
- IMCC 29.87
- BCTX 76.25
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.